male with h/o CLL receiving bendamustine/Rituxan (last dose 7/16), asthma, and recurrent pneumonia, and a recent admission to BMT service [**7-21**] for fevers.
Review of systems is significant for recent 7 lb weight loss over last few months (18 lbs in last 1+years).
Also in the last 2 days having some neck stiffness - he thought it was the placement of his computer at work.
No increase in sputum production, no new nasal discharge.
Denies chest pain, palpitations, shortness of breath.
Denies abd pain, nausea, vomiting, diarrhea or dysuria.
No muscle pain, weakness or numbness.
Extrem warm and well perfused.
He had a head CT which showed sinusitis, no other acute process.
At time of transfer, norepinephrine was at 0.1.  Review of Systems:  as above   Past Medical History: Oncologic history: [**2180**]: diagnosed with CLL [**9-/2185**]: 6 cycles of Fludarabine [**9-/2187**]: 4 cycles of Rituxan/Fludarabine [**11/2188**]: 4 cycles of R-CVP [**10/2189**]: 4 cycles of R-CHOP [**9-/2190**]: 1 cycle Cytoxan/Rituxan [**10/2190**]: 1 cycle of R-CHOP [**12/2190**]: 1st cycle of FCR [**2-/2191**]: 2nd cycle of FCR [**2192-2-1**]: enrolled in protocol 08-052 A Phase I open Label Multiple-Dose, Dose-Escalation Study of MDX-1342 in patients with CD19 Positive Refractory/Relapsed Chronic Lymphocytic Leukemia.
[**2192-5-14**]: Fludarabine/Cytoxan/ Rituxan .
He is founding partner of a large patent law firm, the largest in [**Location (un) 511**] that deals with biomedical and technological patents.
Family History: His mother died of colon cancer at [**Age over 90 **] years and his father died at 62 of a stroke (in context of hypertension).
Physical Exam: GEN:  well-appearing, NAD, speaking in full sentences - conversive and pleasant VS:  T 97.2  112/45  71  22  99% on 2L HEENT: MM moist, no oral lesions, no nystagmus, pupils small but reactive and symmetric, tongue midline CV:  RRR, no murmurs PULM:  good air movement bilat, diffuse expiratory wheezes ABD:  soft, nondistended, nontender, normoactive BS, no guarding or rebound tenderness EXT: No edema SKIN: No rashes, lesions NEURO:  AAOx3, facial sensation intact, strength 5/5 in upper and lower extrem b/l and symmetric, sensation is grossly intact.
No acute intracranial process.
Opacification of the right ethmoid air cells and air-fluid level in the right maxillary sinus.
This can be compatible with acute sinusitis if clinically concordant .
[**8-18**] CXR: New R IJ CVL terminates at mid SVC.
[**8-19**] MRI Head: IMPRESSION: No abnormal meningeal enhancement.
No evidence of acute infarct or hemorrhage.
New left lower base retrocardiac opacity, likely pneumonia, given patient's clinical findings.
Interval worsening of the right lower lobe linear opacities, which may represent atelectasis or superimposed infection.
Mild pulmonary venous congestion.
Worsening perilymphatic ground-glass opacity and more confluent basilar consolidations, compatible with worsening infectious process.
These changes are new on the right and worse on the left since CT from [**2192-9-13**] and radiograph from [**2193-7-21**].
Unchanged diffuse adenopathy with splenomegaly compatible with underlying CLL-related changes.
Mild septal thickening, could be due to mild edema, however lymphatic infiltation is a possibility, (4:141), attention on follow-up is recommended.
Brief Hospital Course: 83 yo M with CLL (undergoing chemotherapy), hx recurrent PNA (last [**Female First Name (un) 564**] on fluconazole) now with fever, confusion, and hypotension c/w sepsis.
# Early sepsis: Presentation with fever and hypotension concerning for early sepsis; was aggressively resuscitated with fluid boluses requiring NorEpi for 5 hours, peaking at 0.08 mcg/kg/min before tapering and discontinuing; maintained CVPs 6-9 with UO averaging >100cc/hr.
Because he is an immunocompromised host he was empirically covered for meningitis (also has had stiff neck).
Started on Meropenem, Vancomycin, and Ampicillin and was transitioned to Vancomycin and Cefepime for broad coverage of possible CNS infection and likely HA-PNA.
Since CSF showed xanthochromia - covered for HSV encephalitis with acyclovir.
MRI showed no acute proccesses.
Pulm and ID were consulted given recurrence of pneumonias and concern for lack of reserve capacity in the future.
pulm f/u with Dr. [**Last Name (STitle) **] who he has seen in the past to discuss possible prophylactic antibiotics.
# Hyponatremia: Likely due to hypovolemia, resolved with aggressive IVF resuscitation.
# HTN: Held atenolol while hypotensive.
-f/u with Dr. [**Last Name (STitle) **] re: recurrent PNA and possibility of prophylactic abx -f/u with Dr. [**Last Name (STitle) 410**] re: CLL  Medications on Admission: ACYCLOVIR - 400 mg tid (generally takes [**Hospital1 **]) ALBUTEROL SULFATE - nebs ALLOPURINOL - 100mg po daily ATENOLOL - 12.5mg po daily FLUCONAZOLE -  100mg po daily FLUTICASONE-SALMETEROL [ADVAIR DISKUS] - 250 mcg-50 mcg/Dose Disk with Device - 1 puff inhaled twice a day SULFAMETHOXAZOLE-TRIMETHOPRIM - 400 mg-80 mg Tablet - 1 (One) Tablet(s) by mouth once a day TAMSULOSIN [FLOMAX] - 0.4 mg Capsule, Sust.
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1) treatment Inhalation every six (6) hours as needed for shortness of breath or wheezing.
Chronic lymphocytic leukemia 3.
Bronchiectasis   Discharge Condition: Mental Status: Clear and coherent.
Discharge Instructions: You were admitted to the hospital with altered mental status, and fever (septic shock).
I encourage you to use your nebulizer treatments every 6 hours as needed for wheezing or difficulty breathing.
If you develop symptoms in the future, you should go to the nearest medical center, even if that is not [**Hospital1 18**].
